111 related articles for article (PubMed ID: 19202699)
21. A case where the principle of "one question, one answer" may work better.
Tada T; Byrne RA; Kastrati A
Am Heart J; 2012 Feb; 163(2):133-5. PubMed ID: 22305827
[No Abstract] [Full Text] [Related]
22. ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevalier B; Dimario C; Fajadet J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Baczynska A; Bagust A; Berenger M; Bos G; Boam A; Bowen JM; Braunwald E; Calle JP; Camenzind E; Campo G; Carlier S; Chevalier B; Daemen J; de Schepper J; Di Bisceglie G; Dimario C; Dobbels H; Fajadet J; Farb A; Ghislain JC; Gitt A; Guagliumi G; Hellbardt S; Hillege HL; Ten Hoedt R; Isaia C; James S; de Jong P; Jüni P; Kastrati A; Klasen E; Kloth S; Kristensen SD; Krucoff M; Legrand V; Lekehal M; Lenarz L; Ni Mhullain F; Nagai H; Patteet A; Paunovic D; Pfisterer M; Potgieter A; Purdy I; Raveau-Landon C; Rothman M; Serruys PW; Silber S; Simoons ML; Steg PG; Tariah I; Ternstrom S; Van Wuytswinkel J; Waliszewski M; Wallentin L; Wijns W; Windecker SW
Eur Heart J; 2009 Jan; 30(2):152-61. PubMed ID: 19036745
[No Abstract] [Full Text] [Related]
23. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial).
La Manna A; Capodanno D; Cera M; Di Salvo ME; Sacchetta G; Corcos T; Prati F; Tamburino C
Am J Cardiol; 2009 Jun; 103(11):1551-5. PubMed ID: 19463514
[TBL] [Abstract][Full Text] [Related]
24. Heightened awareness of the thrombosis potential of drug-eluting stents may save lives.
From RP; Tretsven J; O'Sullivan C
J Clin Anesth; 2008 Dec; 20(8):624-5; author reply 626. PubMed ID: 19100939
[No Abstract] [Full Text] [Related]
25. The drug-eluting stent saga.
Windecker S; Jüni P
Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
[No Abstract] [Full Text] [Related]
26. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
27. [Drug-eluting stents: long-term safety].
Karpov IuA; Samko AN; Buza VV
Ter Arkh; 2009; 81(5):36-41. PubMed ID: 19537584
[TBL] [Abstract][Full Text] [Related]
28. Late in-stent restenosis in a patient with drug-eluting stent.
Sultan FA; Kazmi K; Dhakam S; Quraishi AU
J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
[TBL] [Abstract][Full Text] [Related]
29. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Pendyala L; Jabara R; Robinson K; Chronos N
J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
[TBL] [Abstract][Full Text] [Related]
30. First-generation drug-eluting stents ... and beyond.
Wijns W
Drug Saf; 2009; 32(9):771-3. PubMed ID: 19670916
[No Abstract] [Full Text] [Related]
31. Vascular medicine: a look forward.
Holstein SA; Hohl RJ
Clin Pharmacol Ther; 2009 Aug; 86(2):117-9. PubMed ID: 19621001
[No Abstract] [Full Text] [Related]
32. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
[TBL] [Abstract][Full Text] [Related]
33. Stent design matters: insights from virtual bench testing.
Mortier P; Verdonck PR
Expert Rev Cardiovasc Ther; 2010 May; 8(5):613-5. PubMed ID: 20450292
[No Abstract] [Full Text] [Related]
34. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?
Finn AV; Nakazawa G; Kolodgie F; Virmani R
Eur Heart J; 2009 Aug; 30(15):1828-30. PubMed ID: 19515688
[No Abstract] [Full Text] [Related]
35. Are drug-eluting stents safe in the long term?
Généreux P; Mehran R
CMAJ; 2009 Jan; 180(2):154-5. PubMed ID: 19106153
[No Abstract] [Full Text] [Related]
36. Regarding epidural catheters and drug-eluting stents.
Gerstein NS
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):800-1. PubMed ID: 18922450
[No Abstract] [Full Text] [Related]
37. [Atomic force spectroscopy as a method of prognosis of organism reaction on exogene material].
Aleksieieva TA; Lazarenko ON; Lytvyn PM; Oshkad'orov SP; Lytvyn OS
Klin Khir; 2010 Jan; (1):60. PubMed ID: 20469700
[No Abstract] [Full Text] [Related]
38. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
[TBL] [Abstract][Full Text] [Related]
39. Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Srinivasan J; Jones HR
J Neurol Sci; 2009 Sep; 284(1-2):175-6. PubMed ID: 19358999
[TBL] [Abstract][Full Text] [Related]
40. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
Ayyanathan S; Hersh D; Coplan NL; Garratt K
Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
